Cargando…

Oncolytic effect of SARS-CoV2 in a patient with NK lymphoma

Detalles Bibliográficos
Autores principales:	Pasin, Federico, Mascalchi Calveri, Matteo, Pizzarelli, Ginevra, Calabrese, Alberto, Andreoli, Michele, Bongiovanni, Isabel, Cattaneo, Chiara, Rignanese, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2020
Materias:	Correspondence / Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716983/ https://www.ncbi.nlm.nih.gov/pubmed/32921739 http://dx.doi.org/10.23750/abm.v91i3.10141

Ejemplares similares

Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation
por: Barilà, Gregorio, et al.
Publicado: (2018)

Primary Cutaneous Extranodal Natural Killer (NK) T-Cell Lymphoma: A Case Report
por: Zhang, Si, et al.
Publicado: (2023)

Cure of intravascular NK/T-cell lymphoma of the central nervous system by allogeneic hematopoietic cell transplantation
por: Meissner, Julia, et al.
Publicado: (2022)

Extranodal NK-T-Cell Lymphoma, Nasal-Type Misdiagnosed as Erythema Multiforme with Nasal Fungal Infection
por: Jeong, Soo Hyun, et al.
Publicado: (2022)

Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma
por: Fu, Ruiying, et al.
Publicado: (2023)

Whole exome sequencing identifies recessive germline mutations in FAM160A1 in familial NK/T cell lymphoma
por: Chan, Jason Yongsheng, et al.
Publicado: (2018)

Phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced breast cancer
por: Cousin, Sophie, et al.
Publicado: (2022)

NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer
por: Leung, Elaine Y.L., et al.
Publicado: (2020)

Gender effect in the ITALUNG screening trial. A comparison with UKLS and other trials
por: Puliti, Donella, et al.
Publicado: (2022)

Immune thrombocytopenia following COVID-19 mRNA vaccine: casuality or causality?
por: Pasin, Federico, et al.
Publicado: (2021)

Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcoma
por: Toulmonde, Maud, et al.
Publicado: (2022)

Efficient delivery of oncolytic enterovirus by carrier cell line NK-92
por: Podshivalova, Elizaveta Sergeevna, et al.
Publicado: (2021)

Single VHH-directed BCMA CAR-NK cells for multiple myeloma
por: Ren, Quan, et al.
Publicado: (2023)

Can Parvovirus B19 infection be naturally oncolytic: clinical findings raise such a possibility in leukaemic children
por: Kishore, Janak, et al.
Publicado: (2014)

NK-/T-cell lymphomas
por: Wang, Hua, et al.
Publicado: (2021)

Precise detection of genomic imbalances at single-cell resolution reveals intra-patient heterogeneity in Hodgkin’s lymphoma
por: Mangano, Chiara, et al.
Publicado: (2019)

Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes
por: Tang, Y-T, et al.
Publicado: (2017)

The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma
por: Warricker, Frazer, et al.
Publicado: (2021)

Polytherapeutic strategies with oncolytic virus–bortezomib and adjuvant NK cells in cancer treatment
por: Aspirin, Angelica P., et al.
Publicado: (2021)

CAR-NK cell therapy for hematological malignancies: recent updates from ASH 2022
por: Huang, Ruihao, et al.
Publicado: (2023)

Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation
por: Salvini, Marco, et al.
Publicado: (2021)

The oncogenic fusion protein CBFB-SMMHC downregulates CD48 to evade NK cell recognition
por: Kahlon, Shira, et al.
Publicado: (2018)

Extranodal NK/T cell lymphoma
por: Jeong, Seong Hyun
Publicado: (2020)

Extranodal T- and NK-cell lymphomas
por: de Leval, Laurence, et al.
Publicado: (2022)

Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics
por: Ungerechts, Guy, et al.
Publicado: (2010)

Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization
por: Hohaus, Stefan, et al.
Publicado: (2018)

Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach
por: Faverio, Paola, et al.
Publicado: (2022)

Burkitt's lymphoma of the mandible
por: Kuo, Ying-Shiung, et al.
Publicado: (2017)

CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients
por: Vitallé, Joana, et al.
Publicado: (2019)

Harnessing novel engineered feeder cells expressing activating molecules for optimal expansion of NK cells with potent antitumor activity
por: Min, Bokyung, et al.
Publicado: (2021)

An autopsy case of primary extranodal NK/T cell lymphoma (extranodal NK/T-cell lymphoma) of the bile duct
por: Ito, Hiroyuki, et al.
Publicado: (2019)

Artificial intelligence hallucinations
por: Salvagno, Michele, et al.
Publicado: (2023)

STAT3 Dysregulation in Mature T and NK Cell Lymphomas
por: Seffens, Angelina, et al.
Publicado: (2019)

A Lesson Not To Be Forgotten. Ophthalmologists in Northern Italy Become Internists During the SARS-CoV-2 Pandemic
por: Starace, Vincenzo, et al.
Publicado: (2020)

Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven et al. Joint Bone Spine 2021;88:105258
por: De Marchi, Ginevra, et al.
Publicado: (2022)

Genetic complexity impacts the clinical outcome of follicular lymphoma patients
por: García-Álvarez, María, et al.
Publicado: (2021)

Anaemia Associated with the NK/Lymphoma in Mice
por: Davies, A. J. S., et al.
Publicado: (1962)

The diagnosis and management of NK/T-cell lymphomas
por: Tse, Eric, et al.
Publicado: (2017)

EBV and the Pathogenesis of NK/T Cell Lymphoma
por: Montes-Mojarro, Ivonne A., et al.
Publicado: (2021)

Primary Gastrointestinal T/NK Cell Lymphoma
por: Kim, Eun Kyung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gkarb164e5gee4knqlb8rpplq5